PERRIGO API LTD has a total of 16 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in WIPO (World Intellectual Property Organization), Israel and United States. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are ZHONGSHUAI PHARMACEUTICAL SCI & TECH INC CO LTD, LB PHARMACEUTICALS INC and LIFE MOLECULAR IMAGING SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Israel | 3 | |
#3 | United States | 3 | |
#4 | Canada | 2 | |
#5 | Australia | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Adin Itai | 10 |
#2 | Elazari-Shalom Hila | 6 |
#3 | Rorilk Ori | 6 |
#4 | Sery Yana | 6 |
#5 | Ten Figas Gloria | 4 |
#6 | Fernadez Casares Ana | 4 |
#7 | Weisman Alex | 4 |
#8 | Rozenblat Yevgeny | 4 |
#9 | Ben-Daniel Revital | 3 |
#10 | Kerivonos Sonia | 3 |
Publication | Filing date | Title |
---|---|---|
WO2017203514A1 | Polymorphs of crisaborole and production processes therefor | |
CA2974180A1 | Crystalline forms of efinaconazole | |
EP3122753A2 | Ibrutinib solid forms and production process therefor | |
US2015239862A1 | Process for the preparation of vilanterol and intermediates thereof | |
IL225900D0 | A process for the preparation of nicotine comprising the enzymatic reduction of 4-(methylamino)-1-(pyridin-3-yl)butan-1-one |